Hemogenyx Pharmaceuticals Plc (HEMO.L)

GBp 320.0

(-8.57%)

Gross Profit Summary of Hemogenyx Pharmaceuticals Plc

  • Hemogenyx Pharmaceuticals Plc's latest annual gross profit in 2023 was -645.68 Thousand GBP , up 75.16% from previous year.
  • Hemogenyx Pharmaceuticals Plc's latest quarterly gross profit in 2024 Q2 was -321.68 Thousand GBP , down 0.0% from previous quarter.
  • Hemogenyx Pharmaceuticals Plc reported a annual gross profit of -2.59 Million GBP in annual gross profit 2022, down -816.55% from previous year.
  • Hemogenyx Pharmaceuticals Plc reported a annual gross profit of -283.64 Thousand GBP in annual gross profit 2021, up 19.12% from previous year.
  • Hemogenyx Pharmaceuticals Plc reported a quarterly gross profit of - GBP for 2024 Q1, up 100.0% from previous quarter.
  • Hemogenyx Pharmaceuticals Plc reported a quarterly gross profit of -325.77 Thousand GBP for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Historical Annual Gross Profit of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Year Gross Profit Gross Profit Growth
2023 -645.68 Thousand GBP 75.16%
2022 -2.59 Million GBP -816.55%
2021 -283.64 Thousand GBP 19.12%
2020 -350.71 Thousand GBP 16.86%
2019 -421.81 Thousand GBP -21.12%
2018 -348.26 Thousand GBP -246.6%
2017 -100.48 Thousand GBP 0.0%
2016 - GBP -100.0%
2015 6845.42 GBP 0.0%
2014 - GBP 0.0%

Peer Gross Profit Comparison of Hemogenyx Pharmaceuticals Plc

Name Gross Profit Gross Profit Difference